Dr. Omar Eton
I've won the following awards
Top Oncologist and Hematologist , Massachusetts
Meritorious Service Medal, United States Air Force
American Cancer Society Fellow
Consultant to the Surgeon General for Hematology Oncology
Phase I study of the selective Aurora A kinase inhibitor MLN8054 in patients with advanced solid tumors: safety, pharmacokinetics, and pharmacodynamics.
Molecular cancer therapeutics, 9, 2844-52 (2010)
Melanoma brain metastasis: overview of current management and emerging targeted therapies.
Expert review of neurotherapeutics, 12, 1207-15 (2012)
Phase II trial of imatinib mesylate in patients with metastatic melanoma.
British journal of cancer, 99, 734-40 (2008)
Autologous tumor-derived heat-shock protein peptide complex-96 (HSPPC-96) in patients with metastatic melanoma.
Journal of translational medicine, 8, 9 (2010)
Sequential biochemotherapy versus chemotherapy for metastatic melanoma: results from a phase III randomized trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 20, 2045-52 (2002)
Prognostic factors for survival of patients treated systemically for disseminated melanoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 16, 1103-11 (1998)
Critical analysis of the current American Joint Committee on Cancer staging system for cutaneous melanoma and proposal of a new staging system.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 15, 1039-51 (1997)